SEATTLE (AP) — For the first time, a study shows that a drug used to treat HIV infection also can help prevent it when taken before and after risky sex by gay men.
The anti-HIV procedure, PrEP (pre-exposure prophylaxis), is showing promising results according to a British study.
San Diego, CA (KSWB) -- Every year 50,000 people are diagnosed with HIV in the United States, but a largely unknown blue pill could help cut down the number, according to health officials.
(EDGE) On June 9, The U.S. Food and Drug Administration (FDA) approved the first generic version of emtricitabine/tenofovir disoproxil (Truvada, Gilead Sciences) to both treat and prevent HIV infections in this country.
New York— It’s the Truvada conundrum: A drug hailed as a lifesaver for many people infected by HIV is at the heart of a rancorous debate among gay men, AIDS activists and health professionals over its potential for protecting uninfected men who engage in gay sex without using condoms.
A new trial begins, with hopes of making HIV prevention more practical to the public.
A group of noted AIDS activists issued a statement calling out pharmaceutical giant Gilead over price gouging. The group, which included Peter Staley and Larry Kramer, slammed the makers of PrEP drug Truvada and called for the profiteering to end.